About the offering
When Randy Strause was diagnosed with glioblastoma; an incurable brain cancer, he used medical marijuana but was concerned about the side effects and legal risk of THC. The need was apparent for an over-the-counter product with some of the same benefits of medical marijuana but in a safe, natural, non-toxic, non-intoxicating, consistent quality, measurable, legal, and without stigma. Currently, products containing cannabinoids are either available by prescription only, have long-term health complications, and/or struggle in the state by state medicinal marijuana (MMJ) marketplaces. GR&S was formed to navigate and capitalize on the legal, regulatory and social changes surrounding hemp health products with a single goal from the beginning, “to create the products we wished we had when our father/husband was alive.”
FAQ
How much has G. Randall raised?
G. Randall has raised $25,428 of a $100,000 goal.
Where is G. Randall's campaign listed?
The offering is listed on TruCrowd, an SEC-registered Reg CF intermediary.
What are the terms of G. Randall's raise?
Common Stock, $2.3M cap, $2.30/share.
When does G. Randall's offering close?
The stated close date is Oct 30, 2017.